Khalid bin Mohammed bin Zayed chairs the meeting of the Emirates Council for the genome

Abu Dhabi, March 14 / WAM / His Highness Sheikh Khalid bin Mohammed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi, Chairman of the Executive Council of the Emirate of Abu Dhabi, chaired the meeting of the Emirates Genome Council.
The meeting dealt with the council’s plan to enhance the priority of accurate medicine initiatives that effectively employ genetic data in upgrading public health outcomes in the UAE, and contributes to raising the efficiency of the health care system, stimulating cognitive and economic growth in this vital sector, and establishes the state’s position as an advanced global center in accurate medicine.
His Highness Sheikh Khalid bin Mohammed bin Zayed Al Nahyan stressed the keenness of the rational leadership to continue to improve the health and quality of the lives of community members, noting His Highness the importance of research and development efforts in the fields of precise medicine, preventive care, improving and promoting healthy age, and the contributions of these qualitative efforts in achieving concrete and sustainable results in raising the level of public health.
His Highness praised all the efforts that contribute to enhancing the UAE’s position in the forefront of the leading countries in the field of genome research and their practical applications.
During the meeting, His Highness adopted a new genetic examination package, with the aim of expanding the benefit of genomic data and accelerating the adoption of genetic health care services in the UAE.
This package includes the genetic examinations program for newborns, and aims to early detection of treatment for infants, through the evaluation of 733 gene associated with more than 800 genetic cases.
The package includes the additional genetic tests program for adults involved in the Emirati genome program, with the aim of identifying the genetic cases that can be diagnosed and dealt with early, by evaluating 94 gene associated with more than 50 genetic cases.
It also includes fertile fertility programs, including the evaluation of 186 gene associated with more than 130 genetic cases, and the provision of treatment solutions and personal medical recommendations for couples.
The package also includes the cardiovascular tests program, which provides accurate genetic diagnosis and treatments allocated to it, and supports prevention and early detection, by evaluating more than 800 genes linked to more than 100 genetic cases.
During the meeting, His Highness Sheikh Khalid bin Mohammed bin Zayed Al Nahyan reviewed, during the meeting, the outputs of the Emirati genome study, “Telomer to Telomer” (T2T), which was carried out under the supervision of the Health Department – Abu Dhabi in cooperation with Khalifa University and the “M42” group, with the aim of bridging important gaps in the genomic data, and providing a comprehensive reference source that supports accurate medicine research, enhancing the procedure of comparisons Accurate with global genomic references, with the aim of developing specialized research in diseases and pharmaceutical genome, as well as developing specialized treatment solutions that meet the health needs of Emirati society.
His Highness Sheikh Khalid bin Mohammed bin Zayed Al Nahyan also reviewed the developments of the genetic test for those coming to marriage, which was launched and executed at the national level from January 1, 2025, under the supervision of the Ministry of Health and Community Protection, in cooperation with the Department of Health – Abu Dhabi, the Dubai Health Authority, the Emirates Health Services Corporation, and a number of strategic partners.
Since its launch, the program has provided support to 2,428 of those coming to marriage, as the percentage of genetic compatibility among them reached more than 92%, by conducting accurate genetic checks for 570 genes linked to more than 840 genetic disorders.
The program also provided genetic consulting sessions for couples whose results showed their need for further support, to assess possible genetic risk factors, and to provide studied solutions that support the decision -making process.
The program aims to enhance public health and the quality of community members, and protect future generations from genetic diseases.
His Highness Sheikh Khalid bin Mohammed bin Zayed Al Nahyan reviewed the latest developments in the Emirati genome program, which succeeded in collecting more than 700,000 genetic samples from the country’s citizens, achieving remarkable progress towards his strategic goal by reaching one million samples.
The program also enabled, recently, to collect 100,000 additional genetic samples from participants of multiple nationalities, as part of a new qualitative initiative implemented in cooperation with the “M42” group to take advantage of the advanced capabilities of the UAE in the field of genome.

This new initiative contributes to bridging important gaps in genetic data at the global level, and providing accurate scientific visions about genetic mutations that affect more than 2.5 billion people from different races, with the aim of enhancing international cooperation in the fields of accurate medicine research and solutions.
The “Emirati genome program” is one of the main national projects within the national genome strategy and contributes to a qualitative shift in the state’s health care services, by providing high -quality genetic data, helping researchers, doctors and scientists to identify the causes of genetic diseases, understand the nature of genetic mutations, and predict genetic preparation for some diseases, and developing effective personal health care plans for Emirati society.
The meeting was attended by His Excellency Muhammad Abdullah Al -Qarqawi, Minister of Cabinet Affairs, His Excellency Sarah Bint Youssef Al -Amiri, Minister of Education and His Excellency Omar Sultan Al -Ulama, Minister of State for Artificial Intelligence, Digital Economy and remote work applications; His Excellency Mansour Ibrahim Al -Mansoori, Head of the Health Department – Abu Dhabi; His Excellency Saif Saeed Ghobash, Secretary -General of the Executive Council of the Emirate of Abu Dhabi and His Excellency Dr. Amer Ahmed Al Sharif, Executive Director of Dubai Health and Director of Mohammed bin Rashid University for Medicine and Health Sciences and His Excellency Dr. Youssef Mohamed Al Serkal, Director General of the Emirates Health Services Association.

• For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Twitter